JAB Acquisition units begin separate trading Aug. 5 on Nasdaq
Reuters2026/08/04 15:47- JAB Acquisition will allow separate trading of its 17.25 million IPO units starting Aug. 5, 2026.
- Each unit includes 1 Class A ordinary share, 1 right for 1/4 share, 1 warrant to buy 1 share at USD 11.5.
- Unseparated units keep trading as JABRU; separated securities trade as JAB, JABRR, JABRW.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Competition in US oral weight-loss drugs intensifies! Eli Lilly (LLY.US) Foundayo captures 30% of new patients, narrowing Novo Nordisk's (NVO.US) first-mover advantage
Eli Lilly stated on Monday that its oral weight-loss drug, Foundayo, has captured over 30% of the market share among new patients in the US oral obesity treatment market, narrowing the early lead achieved by Danish competitor Novo Nordisk with its Wegovy oral tablets.

2-Yr Benchmark Govt Yields - Germany vs Other Nations
2-Yr Benchmark Govt Yields - U.S. vs Other Nations
10-Yr Benchmark Govt Yields - U.S. vs Other Nations